Celanese (NYSE: CE) insider transactions
In the twelve months to 10 November 2026, executives and directors of Celanese reported 0 open-market sales and 7 open-market purchases of 13,853 shares ($593,258), by 4 people, according to the Form 4 filings they submitted to the SEC.
Latest transactions
| Date | Insider | Role | Transaction | Shares | Price | Held after | Filing |
|---|---|---|---|---|---|---|---|
| 6 November 2026 | Fernandez-moreno Luis M | Director | Grant or award | +2,435 | — | 2,435 | Form 4 |
| 14 August 2026 | Kyrish Chuck | SVP & CFO | Open-market purchase | +1,400 | $45.53 | 28,214 | Form 4 |
| 14 August 2026 | Kyrish Chuck | SVP & CFO | Open-market purchase | +100 | $45.51 | 28,314 | Form 4 |
| 14 August 2026 | Kyrish Chuck | SVP & CFO | Open-market purchase | +800 | $45.51 | 29,114 | Form 4 |
| 11 August 2026 | Duffie Ashley B | SVP & GC | Open-market purchase | +600 | $45.60 | 31,925 | Form 4 |
| 11 August 2026 | Murray Mark Christopher | SVP - Acetyls | Open-market purchase | +2,153 | $45.52 | 30,432 | Form 4 |
| 10 August 2026 | Galante Edward G | Director | Grant or award | +1,930 | — | 27,983 | Form 4 |
| 11 May 2026 | Galante Edward G | Director | Grant or award | +4,676 | — | 26,053 | Form 4 |
| 11 May 2026 | Moorthy Ganesh | Director | Grant or award | +2,975 | — | 8,990 | Form 4 |
| 11 May 2026 | Rucker Kim K.W. | Director | Grant or award | +2,975 | — | 3,031 | Form 4 |
| 11 May 2026 | Hill Kathryn | Director | Grant or award | +2,975 | — | 19,783 | Form 4 |
| 11 May 2026 | Kuehn Christopher J | Director | Grant or award | +2,975 | — | 2,975 | Form 4 |
| 11 May 2026 | Noonan Anne P | Director | Grant or award | +2,975 | — | 2,975 | Form 4 |
| 11 May 2026 | Kissire Deborah J. | Director | Grant or award | +2,975 | — | 4,075 | Form 4 |
| 11 May 2026 | Koenig Michael | Director | Grant or award | +2,975 | — | 8,320 | Form 4 |
| 11 May 2026 | Chinn Bruce E. | Director | Grant or award | +2,975 | — | 7,261 | Form 4 |
| 9 May 2026 | Rucker Kim K.W. | Director | Returned to the company | −3,376 | — | 56 | Form 4 |
| 9 May 2026 | Kuehn Christopher J | Director | Returned to the company | −3,376 | — | 0 | Form 4 |
| 9 May 2026 | Kissire Deborah J. | Director | Returned to the company | −3,376 | — | 1,100 | Form 4 |
| 9 May 2026 | Koenig Michael | Director | Shares withheld for tax | −1,013 | $57.51 | 5,345 | Form 4 |
Names appear as in the filing, surname first. A dash in the price column means the filing reports none, as in grants and gifts.
How to read the table
Only open-market purchases and sales are trades the insider chose to make at the market price, and they are the ones counted in the summary above. Grants, option exercises and shares withheld for tax come from pay plans. A sale marked as a 10b5-1 plan was scheduled in advance under a written plan.
Where each row comes from
From the Form 4 that each executive, director or large shareholder must file with the SEC within two business days of a transaction, read up to 10 November 2026. Each row links to its filing on EDGAR. Only transactions in shares are listed, not derivatives, and amended filings are left out. The accounts of the company are on the Celanese page; the method, in data sources.
Information prepared from the Form 4 filings submitted to the SEC, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.